Peptide Therapeutics Market Growing at 7.16% CAGR to Reach USD 70.20 Bn by 2031 Driven by Rising Cancer Prevalence & Metabolic Disorder Burden, Reports Mordor Intelligence
HYDERABAD, India, March 25, 2026 /PRNewswire/ -- According to Mordor Intelligence, the peptide therapeutics market size is valued at USD 49.68 billion in 2026, and is projected to reach USD 70.20 billion by 2031, registering a CAGR of 7.16% over the forecast period (2026–2031), driven by increasing demand for targeted therapies, rising prevalence of chronic diseases, and advancements in peptide synthesis and drug delivery technologies. The growing application of peptide-based drugs across oncology, metabolic disorders, and infectious diseases is supporting widespread adoption across global healthcare systems.
The peptide therapeutics market is evolving as pharmaceutical companies increasingly focus on developing highly specific and effective treatment options with improved safety profiles. Peptides offer advantages such as high specificity, low toxicity, and better biological activity, making them suitable for a wide range of therapeutic applications. Continuous innovation in peptide engineering, including modifications to enhance stability and bioavailability, is further strengthening the market landscape. Market growth is also supported by the increasing burden of chronic conditions such as cancer, diabetes, and cardiovascular diseases, which require advanced and targeted treatment approaches. As healthcare systems shift toward precision and personalized medicine, peptide therapeutics are gaining traction as an important class of biologically active compounds. Additionally, advancements in drug delivery technologies, including injectable and oral peptide formulations, are improving patient compliance and expanding clinical use.
Peptide Therapeutics Market Share by Region
North America represents a significant share of the peptide therapeutics market, driven by strong research and development investments, advanced healthcare infrastructure, and the presence of major pharmaceutical companies. The region continues to lead in innovation and adoption of peptide-based therapies.
Europe holds a notable position in the market, supported by growing research initiatives, favorable regulatory frameworks, and increasing focus on advanced therapeutics.
Asia-Pacific is emerging as a high-growth region due to rising healthcare expenditure, expanding pharmaceutical manufacturing capabilities, and increasing awareness of advanced treatment options.
"Rising clinical adoption of peptide-based therapies reflects steady progress in targeted treatment approaches across multiple indications. This assessment draws on consistently updated datasets and cross-verified sources, offering decision-makers a balanced, evidence-led view aligned with observable market developments," says Soumya Goud, Senior Research Manager, Mordor Intelligence.
Peptide Therapeutics Market Trends & Forecast
Growing Adoption of Peptide-Based Targeted Therapies: Peptide therapeutics are increasingly being used in targeted treatment approaches due to their high specificity and ability to interact with biological targets effectively, particularly in oncology and metabolic disorders.
Advancements in Peptide Synthesis and Drug Delivery Technologies: Innovations in synthesis techniques and delivery systems improve peptide stability, bioavailability, and ease of administration, supporting broader clinical applications.
Peptide Therapeutics Market Segmentation Overview
By Marketing Type
- Branded
- Generic
By Application
- Oncology
- Metabolic Disorders
- Cardiovascular Disorders
- Infectious Diseases
- Gastrointestinal Disorders
- CNS Disorders
By Route of Administration
- Parenteral
- Oral
- Pulmonary & Nasal
- Transdermal & Implantable
By Technology
- Solid-Phase Peptide Synthesis (SPPS)
- Liquid-Phase Peptide Synthesis (LPPS)
- Hybrid & Flow Chemistry
- Recombinant Expression
By End User
- Hospitals & Clinics
- Research Institutes
- Pharmaceutical & Biotech Companies
By Geography
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
- South America
- Brazil
- Argentina
- Rest of South America
For a full breakdown of market dynamics, segmentation insights, regional analysis, and competitive landscape, access the details of the Mordor Intelligence report: https://www.mordorintelligence.com/industry-reports/peptide-therapeutics-market?utm_source=prnewswire
Peptide Therapeutics Market Competitive Outlook
The peptide therapeutics market features a mix of global pharmaceutical companies and specialized biotechnology firms focusing on innovation, pipeline expansion, and strategic collaborations. Market participants are investing in advanced peptide platforms, improving manufacturing capabilities, and expanding their therapeutic portfolios to address evolving healthcare needs.
Major Companies include:
- Amgen Inc.
- AstraZeneca plc
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd
- Novo Nordisk A/S
- Pfizer Inc.
- Sanofi S.A.
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd.
- GlaxoSmithKline plc
Industry Related Reports by Mordor Intelligence
Anesthesia Drugs Market Size - The anesthesia drugs market is projected to grow from USD 7.77 billion in 2026 to USD 9.30 billion by 2031, registering a CAGR of 3.65% during the forecast period. Growth is driven by increasing surgical procedures, rising demand for safe and effective anesthetic agents, and expanding healthcare infrastructure across emerging and developed markets.
Baxter International Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Pfizer Inc. and Aspen Pharmacare Holdings Ltd. are the major companies operating in this market.
Read more about companies in the anesthesia drugs market: https://www.mordorintelligence.com/industry-reports/global-anesthesia-drugs-market-industry/companies?utm_source=prnewswire
India Pharmaceuticals Market Trends - The India pharmaceuticals market is estimated to grow from USD 60.32 billion in 2026 to USD 79.74 billion by 2031, registering a CAGR of 5.74% during the forecast period. Market expansion is supported by strong generic drug manufacturing, increasing domestic demand for medicines, and growing export opportunities across global markets.
Sun Pharmaceutical Industries Limited, Cipla Pharmaceuticals, Dr. Reddy's laboratories, Torrent Pharmaceuticals and Cipla Ltd. are the major companies operating in this market.
Read more about companies in the India pharmaceuticals market: https://www.mordorintelligence.com/industry-reports/pharmaceuticals-industry-in-india/companies?utm_source=prnewswire
Botulinum Toxin Market Share - The botulinum toxin market is expected to grow from USD 13.87 billion in 2026 to USD 20.94 billion by 2031, at a CAGR of 8.59% over the forecast period. Growth is driven by rising demand for aesthetic procedures, increasing therapeutic applications in neurology and dermatology, and expanding awareness of minimally invasive cosmetic treatments.
Evolus, AbbVie, Merz, Ipsen Pharma and Galderma are the major companies operating in this market.
Read more about companies in the botulinum toxin market: https://www.mordorintelligence.com/industry-reports/global-botulinum-toxin-market/companies?utm_source=prnewswire
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries, please contact:
[email protected]
https://www.mordorintelligence.com/contact-us
Logo: https://mma.prnewswire.com/media/2746908/Mordor_Intelligence_Logo.jpg
SOURCE Mordor Intelligence Private Limited
Share this article